Big Patent Expirations of 2010
2010 will still see patent expirations of some of the industry's blockbuster drugs. Teva, Apotex, Mylanand a slew of other generic drugmakers will have a chance to put a dent in the sales of a number of brand meds this year--including Flomax and Aricept. Lipitor, whose basic patent expires this year, doesn't face competition until 2011 because of Pfizer's deal with Ranbaxy, the first-filer. It's still included in the following list, which has a number of top-selling drugs.
Our 2010 patent expiration list also includes drugs whose patent actually expires, but managed to get a six-month extension due to pediatric exclusivity.
Ver
Ver anterior...
No hay comentarios:
Publicar un comentario